INS and Hyperglycemia: Considering the chronic hyperglycemia-induced glucotoxicity in these patients, as well as the potential confounding effects of insulin, insulin sensitizers, and insulin secretagogues on traditional insulin resistance indices such as HOMA-IR, HOMA-β, and QUICKI, we chose to concentrate on the recently proposed novel index, the TyG index.